Research Analysts Set Expectations for Fortrea Q1 Earnings

Fortrea Holdings Inc. (NASDAQ:FTRE) – William Blair dropped their Q1 2025 earnings per share estimates for shares of Fortrea in a research report issued to clients and investors on Monday, March 3rd. William Blair analyst M. Smock now forecasts that the company will post earnings of ($0.24) per share for the quarter, down from their prior estimate of $0.28. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for Fortrea’s current full-year earnings is $0.51 per share. William Blair also issued estimates for Fortrea’s Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at $0.23 EPS, FY2025 earnings at $0.37 EPS, Q1 2026 earnings at ($0.12) EPS, Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.40 EPS and FY2026 earnings at $0.67 EPS.

A number of other analysts also recently commented on FTRE. Barclays reduced their price objective on Fortrea from $25.00 to $12.00 and set an “equal weight” rating for the company in a research report on Tuesday. Evercore ISI lowered their target price on shares of Fortrea from $20.00 to $15.00 and set an “in-line” rating on the stock in a research note on Tuesday. The Goldman Sachs Group dropped their price target on shares of Fortrea from $22.00 to $11.00 and set a “neutral” rating for the company in a research report on Tuesday. TD Cowen upped their price objective on Fortrea from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, November 11th. Finally, Robert W. Baird downgraded Fortrea from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $28.00 to $25.00 in a research report on Friday, December 6th. One analyst has rated the stock with a sell rating and eleven have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.30.

Fortrea Price Performance

Shares of NASDAQ:FTRE opened at $10.89 on Thursday. Fortrea has a twelve month low of $9.55 and a twelve month high of $41.02. The business has a 50 day moving average price of $16.66 and a 200 day moving average price of $19.01. The company has a market cap of $976.83 million, a price-to-earnings ratio of -3.18, a PEG ratio of 1.78 and a beta of 1.34. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.74.

Fortrea (NASDAQ:FTRE) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.18). Fortrea had a positive return on equity of 2.00% and a negative net margin of 10.99%. The firm had revenue of $697.00 million for the quarter, compared to analysts’ expectations of $703.22 million. During the same quarter in the previous year, the firm posted $0.19 earnings per share.

Insider Activity

In related news, CEO Thomas Pike sold 11,268 shares of the company’s stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $18.04, for a total value of $203,274.72. Following the completion of the sale, the chief executive officer now owns 159,868 shares in the company, valued at approximately $2,884,018.72. This represents a 6.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last quarter, insiders have sold 12,386 shares of company stock valued at $219,751. 0.12% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Hara Capital LLC acquired a new stake in shares of Fortrea in the 3rd quarter valued at about $29,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Fortrea in the 4th quarter valued at approximately $30,000. GF Fund Management CO. LTD. bought a new stake in Fortrea in the 4th quarter valued at approximately $35,000. Covestor Ltd grew its stake in shares of Fortrea by 102.4% during the 3rd quarter. Covestor Ltd now owns 2,763 shares of the company’s stock worth $55,000 after acquiring an additional 1,398 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Fortrea by 21.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,241 shares of the company’s stock worth $64,000 after purchasing an additional 572 shares in the last quarter.

Fortrea Company Profile

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.